High Stakes for Low Adherence
High Stakes for Low Adherence
Diane Havlir
NULL
*Correspondence: Diane Havlir, Email not available
Abstract
All clinicians are well aware that adherence toantiretroviral therapy is a critical determinant ofoutcome. While dosing regimens for current firstline therapy represent a significant improvementfrom their predecessors, these therapies still provideenormous adherence challenges for theuninitiated patient.
